Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-01-21Clinical Trial Update: An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection [Phase 2]
A Phase 2 extension study evaluating the safety and efficacy of celgosivir with peginterferon alfa-2b, with or without ribavirin, in patient…
-
CLINICAL_TRIALS trial_result · 2008-01-15Clinical Trial Update: Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin [Phase 3]
A Phase 3 clinical trial evaluating thymosin in combination with pegylated interferon for non-cirrhotic hepatitis C patients who did not res…
-
CLINICAL_TRIALS trial_result · 2008-01-15Clinical Trial Update: Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin [Phase 3]
Phase 3 clinical trial evaluating Thymosin in combination with PEG-Interferon in hepatitis C patients with cirrhosis who did not respond to …
-
CLINICAL_TRIALS trial_result · 2008-01-11Clinical Trial Update: Short Course of Interferon Treatment in Patients With HCV Infection [Phase 4]
A Phase 4 clinical trial evaluating a short course of interferon for Hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2007-12-21Clinical Trial Update: Phase 2 Study of VX-950, Pegasys and Copegus in Hepatitis C [Phase 2]
A Phase 2 trial investigating VX-950 (telaprevir) in combination with Pegasys and Copegus for Hepatitis C has completed. The update notes th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-12-21Clinical Trial Update: VX-950 and Peginterferon for Hepatitis C [Phase 1]
A Phase 1 trial evaluating VX-950 (telaprevir) in combination with Peginterferon for Hepatitis C has completed. The release does not provide…
-
CLINICAL_TRIALS trial_result · 2007-12-21Clinical Trial Update: Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C [Phase 2]
Phase 2 trial update on Merimepodib (MMPD) in a triple-drug regimen for chronic hepatitis C; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2007-12-21Clinical Trial Update: Safety and PK Study of NOV-205 to Treat Chronic HCV Who Fail Standard Therapy [Phase 1]
This release covers a Phase 1 safety and pharmacokinetics study of NOV-205 in chronic hepatitis C patients who failed standard therapy.
-
CLINICAL_TRIALS research · 2007-12-14Clinical Trial Update: Reducing Depressive Symptoms During HCV Therapy: A Randomized Study [NA]
A randomized clinical trial update evaluating strategies to reduce depressive symptoms in people undergoing hepatitis C therapy.
-
CLINICAL_TRIALS trial_result · 2007-11-30Clinical Trial Update: Health Behavior Feedback Study for Veterans With Hepatitis C [Phase 1]
A Phase 1 clinical trial update reports the completion of a health behavior feedback study for veterans with Hepatitis C and related alcohol…
-
CLINICAL_TRIALS trial_result · 2007-11-22Clinical Trial Update: Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis C [Phase 4]
Phase 4 trial evaluating losartan for hepatic fibrogenesis in chronic hepatitis C has completed. The study investigated whether losartan cou…
-
CLINICAL_TRIALS trial_result · 2007-11-16Clinical Trial Update: Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients [Phase 2]
Phase 2 trial assessing the efficacy and safety of adding interleukin-2 to pegylated interferon alfa-2a and ribavirin in patients coinfected…
-
CLINICAL_TRIALS withdrawal · 2007-11-06Clinical Trial Update: Safety, Tolerability and Efficacy of XTL 2125 in HCV-Infected Patients Who Are Interferon-Alpha Non-Responders or Relapsers [Phase 1]
A Phase 1 study evaluating the safety, tolerability, and preliminary efficacy of XTL 2125 in chronic hepatitis C virus infection patients wh…
-
CLINICAL_TRIALS trial_result · 2007-11-01Clinical Trial Update: Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis [Phase 2]
A Phase 2 trial assessed the safety and efficacy of Interferon Gamma-1b in hepatitis C patients with liver fibrosis or cirrhosis. The study …
-
CLINICAL_TRIALS research · 2007-11-01Clinical Trial Update: Assessing the Efficacy and Safety of Rosiglitazone Added to Standard Therapy for Hepatitis C Genotype 1 With Fatty Liver [Phase 4]
Clinical trial update reporting the termination of a Phase 4 study assessing rosiglitazone added to standard therapy for hepatitis C genotyp…
-
CLINICAL_TRIALS trial_result · 2007-10-19Clinical Trial Update: Treatment Insulin Resistence in HCV G-1 Patient [Phase 4]
Phase 4 clinical trial update on insulin resistance treatment in a patient with genotype 1 chronic hepatitis C, which has completed.
-
CLINICAL_TRIALS trial_result · 2007-08-30Clinical Trial Update: Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C [Phase 2]
Phase 2 clinical trial evaluating a three-drug combination of interferon gamma, pegylated interferon alpha-2a, and ribavirin in chronic hepa…
-
CLINICAL_TRIALS trial_result · 2007-08-23Clinical Trial Update: Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C [Phase 2]
Phase 2 trial of Omega Interferon alone or in combination with Ribavirin for Hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2007-08-13Clinical Trial Update: Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C [Phase 3]
Phase 3 clinical trial evaluating peginterferon alfa-2a plus ribavirin for chronic hepatitis B and hepatitis C co-infection and chronic hepa…
-
CLINICAL_TRIALS trial_result · 2007-08-01Clinical Trial Update: Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection
An update on a clinical trial examining how pharmacogenomics influences interferon and ribavirin treatment for chronic hepatitis C virus inf…
-
CLINICAL_TRIALS trial_result · 2007-06-13Clinical Trial Update: Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients [Phase 2]
This clinical trial update reports Phase 2 results for treating chronic hepatitis C in HIV-infected patients with pegylated interferon alfa-…
-
CLINICAL_TRIALS trial_result · 2007-06-13Clinical Trial Update: Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected Patients [Phase 3]
Phase 3 trial update of peginterferon alfa-2a plus ribavirin plus amantadine for chronic hepatitis C; the study has completed.
-
CLINICAL_TRIALS trial_result · 2007-04-27Clinical Trial Update: Ribavirin/Pegasys Treatment of Recurrent Hepatitis C After Liver Transplant [Phase 3]
A Phase 3 clinical trial evaluating ribavirin in combination with Pegasys (pegylated interferon alfa-2a) for recurrent hepatitis C after liv…
-
CLINICAL_TRIALS trial_result · 2007-04-24Clinical Trial Update: Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211) [Phase 3]
Phase 3 trial ANRS 1211 evaluating pegylated interferon plus ribavirin for treatment-naive chronic hepatitis C in Egyptian patients has comp…
-
CLINICAL_TRIALS trial_result · 2007-04-23Clinical Trial Update: Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication [Phase 3]
A Phase 3 trial evaluating tolerability of peginterferon plus ribavirin in chronic hepatitis C with and without antiretroviral therapy for H…